Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Researcher

Endocrinology · China · 2025-06-07

Processing Time
19 days
Decision Date
2025-06-07
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to investigate the molecular mechanisms and signaling pathways involved in endocrine and autoimmune thyroid diseases to identify therapeutic targets. The work utilizes advanced molecular biology techniques, cell culture systems, and animal models to develop effective treatments for conditions impacting a large portion of the U.S. population.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses endocrine and autoimmune thyroid diseases which pose significant health and economic challenges to the U.S. population.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 12 publications, 70 citations, and 11 peer reviews demonstrates a high level of expertise and influence in the field.

3 Balance of Interests Met

The petitioner's ability to provide cutting-edge solutions that minimize unnecessary medical procedures makes her an asset to U.S. medical research.

Why This Petition Was Approved

The petition was approved based on the petitioner's authorship of 12 peer-reviewed journal articles and 70 citations, with 5 papers ranking in the top 10% of their field. The case included evidence of 11 peer reviews for high-impact journals and two expert recommendation letters confirming the national importance of the research. All three Dhanasar prongs were satisfied within a rapid 19-day premium processing window.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Conference Presentations
Judging Experience
Original Contributions

Similar Cases

Pathologist

Healthcare · Taiwan

WeGreened EB-2 (NIW) approved
129 days 2022-03-19
The petitioner proposes to identify genetic mutations that drive cancer development using expertise in histopathology and molecular diagnostics. Her work focuses on discovering new therapeutic targets and reinventing laboratory workflows to facilitate personalized medicine for thyroid, head and neck, and renal cell carcinomas.
View Case

Postdoctoral Researcher

Research and Development · Brazil

WeGreened EB-2 (NIW) approved
Texas 265 days 2025-07-23
The petitioner proposes to continue her research in endocrine oncology, specifically focusing on the validation and clinical application of circulating tumor DNA (ctDNA) to detect molecular residual disease. Her work involves coordinating multi-institutional clinical trials and analyzing tumor genetic profiles to optimize treatment strategies for both malignant and benign adrenal lesions. The goal is to improve recurrence-free survival and therapeutic responses for cancer patients undergoing chemotherapy and immunotherapy.

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Ohio 90 days 2025-01-24
The petitioner proposes to continue his research into the role of immune cells in human diseases, specifically focusing on autoimmunity and tumors. His work aims to develop novel immunotherapies for Diffuse Intrinsic Pontine Glioma (DIPG) and identify new therapeutic targets to improve treatments for cancer and autoimmune conditions.
View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 60 days 2025-02-15
The petitioner proposes to use advanced in vitro functional approaches to study disease mechanisms and identify drug targets for cancer, obesity, and autoimmune disorders. Her work specifically focuses on advancing personalized cancer treatments by identifying precise drug targets and improving immune regulation.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-07.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 19 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist